Published in Infect Control Hosp Epidemiol on September 01, 2008
Multilocus sequence typing of Clostridium difficile. J Clin Microbiol (2009) 4.16
Burden of Clostridium difficile on the healthcare system. Clin Infect Dis (2012) 3.20
The economic burden of Clostridium difficile. Clin Microbiol Infect (2011) 1.74
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol (2010) 1.58
Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. Biol Blood Marrow Transplant (2013) 1.58
Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis (2012) 1.55
Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med (2011) 1.48
Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease. J Clin Microbiol (2010) 1.38
Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J Clin Microbiol (2009) 1.33
The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. CMAJ (2011) 1.31
The potential economic value of screening hospital admissions for Clostridium difficile. Eur J Clin Microbiol Infect Dis (2012) 1.04
Vitamin D's potential to reduce the risk of hospital-acquired infections. Dermatoendocrinol (2012) 1.01
Tube feeding, the microbiota, and Clostridium difficile infection. World J Gastroenterol (2010) 1.01
Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection. J Clin Microbiol (2012) 1.00
Commentary: preventing Clostridium difficile-associated disease: is it time to pay the piper? Infect Control Hosp Epidemiol (2008) 0.87
Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS (2013) 0.87
Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol (2016) 0.86
Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy. Support Care Cancer (2014) 0.83
The epidemiology and economic burden of Clostridium difficile infection in Korea. Biomed Res Int (2015) 0.82
Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections. Antimicrob Resist Infect Control (2012) 0.80
Presence and molecular characterization of Clostridium difficile and Clostridium perfringens in intestinal compartments of healthy horses. BMC Vet Res (2012) 0.80
Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach. BMC Infect Dis (2016) 0.78
Mortality, Hospital Costs, Payments, and Readmissions Associated With Clostridium difficile Infection Among Medicare Beneficiaries. Infect Dis Clin Pract (Baltim Md) (2015) 0.77
Prevalence and management of antibiotic associated diarrhea in general hospitals. BMC Infect Dis (2015) 0.77
Acute Renal Failure in Association with Community-Acquired Clostridium difficile Infection and McKittrick-Wheelock Syndrome. Case Rep Gastroenterol (2011) 0.77
Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI. Am J Infect Control (2016) 0.77
Cost and Impact on Patient Length of Stay of Rapid Molecular Testing for Clostridium difficile. Infect Dis Ther (2014) 0.75
Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study. BMC Geriatr (2016) 0.75
Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis (2016) 0.75
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 24.91
Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med (2013) 11.85
Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA (2002) 10.40
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis (2008) 9.57
Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis (2005) 8.77
Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med (2013) 7.75
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.59
Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59
Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis (2004) 6.13
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med (2004) 5.47
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis (2003) 5.21
Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm (2013) 5.02
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis (2010) 4.98
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis (2008) 4.79
Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis (2009) 4.33
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis (2007) 3.73
Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med (2008) 3.67
The future of antibiotics and resistance. N Engl J Med (2013) 3.47
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis (2003) 3.39
Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med (2004) 3.30
Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 3.13
Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis (2003) 2.99
Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol (2007) 2.77
Improvement in the health of HIV-infected persons in care: reducing disparities. Clin Infect Dis (2012) 2.70
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recomm Rep (2002) 2.70
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) (2010) 2.67
Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice. Clin Infect Dis (2011) 2.49
It is time to implement routine, not risk-based, HIV testing. Clin Infect Dis (2005) 2.40
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med (2002) 2.36
Google Flu Trends: correlation with emergency department influenza rates and crowding metrics. Clin Infect Dis (2012) 2.34
A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.32
Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.30
Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev (2011) 2.22
Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.22
Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis (2008) 2.16
A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol (2002) 2.08
Vancomycin resistance in staphylococci. Clin Microbiol Rev (2002) 2.07
Destroying the life and career of a valued physician-scientist who tried to protect us from plague: was it really necessary? Clin Infect Dis (2005) 2.06
Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis (2006) 1.97
Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet (2013) 1.94
Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu Rev Microbiol (2011) 1.94
A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol (2006) 1.93
An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis (2012) 1.90
Contact precautions: more is not necessarily better. Infect Control Hosp Epidemiol (2014) 1.88
Catheter duration and risk of CLA-BSI in neonates with PICCs. Pediatrics (2010) 1.88
Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis (2007) 1.87
Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.84
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis (2009) 1.83
Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.81
The critically ill child with novel H1N1 influenza A: a case series. Pediatr Crit Care Med (2010) 1.77
First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother (2011) 1.74
Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.66
An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med (2003) 1.65
Reduction of catheter-associated bloodstream infections in pediatric patients: experimentation and reality. Pediatr Crit Care Med (2008) 1.63
Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med (2002) 1.60
Middle East respiratory syndrome coronavirus in healthcare settings. Curr Opin Infect Dis (2015) 1.60
Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) (2013) 1.60
An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA (2004) 1.59
HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections. J Acquir Immune Defic Syndr (2008) 1.57
Enhanced identification of postoperative infections among inpatients. Emerg Infect Dis (2004) 1.56
Knowledge, awareness, and attitudes regarding methicillin-resistant Staphylococcus aureus among caregivers of hospitalized children. J Pediatr (2010) 1.54
The new Clostridium difficile--what does it mean? N Engl J Med (2005) 1.53
Influenza A (H5N1): will it be the next pandemic influenza? Are we ready? Ann Intern Med (2005) 1.52
Past history of skin infection and risk of surgical site infection after elective surgery. Ann Surg (2013) 1.52
A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol (2006) 1.51
Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis (2002) 1.51
Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance. Clin Infect Dis (2013) 1.50
Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol (2003) 1.47
Seeding of a cavernous angioma with Mycoplasma hominis: case report. Neurosurgery (2003) 1.47
Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol (2003) 1.46
Bronchoscope reprocessing and infection prevention and control: bronchoscopy-specific guidelines are needed. Chest (2004) 1.45
Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis (2006) 1.44
Electronic-eye faucets: Legionella species contamination in healthcare settings. Infect Control Hosp Epidemiol (2012) 1.42
Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol (2005) 1.41
Risk factors for positive admission surveillance cultures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in a neurocritical care unit. Crit Care Med (2011) 1.41
Community-associated methicillin-resistant Staphylococcus aureus strains in pediatric intensive care unit. Emerg Infect Dis (2010) 1.35
Combining free text and structured electronic medical record entries to detect acute respiratory infections. PLoS One (2010) 1.35
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis (2011) 1.34
Protecting health care workers from Ebola: personal protective equipment is critical but is not enough. Ann Intern Med (2014) 1.31
Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. Am J Epidemiol (2005) 1.31
How will we know patients are safer? An organization-wide approach to measuring and improving safety. Crit Care Med (2006) 1.28
Antiretroviral therapy where resources are limited. N Engl J Med (2003) 1.27
Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clin Infect Dis (2011) 1.26
Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. Arch Intern Med (2005) 1.23
Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med (2005) 1.23
How parents of children receiving pediatric palliative care use religion, spirituality, or life philosophy in tough times. J Palliat Med (2011) 1.22
Orchestrated scientific collaboration: critical to the control of MERS-CoV. Ann Intern Med (2015) 1.21
The role of anaerobic bacteria in lung abscess. Clin Infect Dis (2005) 1.20
Evaluation of a rapid fluorescent staining method for detection of mycobacteria in clinical specimens. J Clin Microbiol (2009) 1.18